Brief: Mendus Announces USPTO Patent Grant For Vididencel In Ovarian Cancer

Mendus AB (publ)

23/07/2025 07:06

July 23 (Reuters) - Mendus AB (publ) IMMUN.ST:

ANNOUNCES UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) PATENT GRANT FOR VIDIDENCEL IN OVARIAN CANCER

Source text: ID:nMFN6YhrXF

Further company coverage: IMMUN.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))